Cornerstone Capital Management Holdings’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$872K	Buy	69,573 +2,865	+4%	+$37.4K	0.01%	926
2017 Q3	$880K	Sell	66,708 -4,895	-7%	-$67.4K	0.01%	954
2017 Q2	$1.13M	Sell	71,603 -9,268	-11%	-$135K	0.01%	877
2017 Q1	$1.16M	Buy	80,871 +55,335	+217%	+$757K	0.01%	892
2016 Q4	$326K	Sell	25,536 -91,699	-78%	-$1.16M	﹤0.01%	1142
2016 Q3	$1.56M	Buy	117,235 +103,265	+739%	+$1.21M	0.01%	843
2016 Q2	$153K	Buy	13,970 +4,537	+48%	+$44.3K	﹤0.01%	1236
2016 Q1	$86K	Sell	9,433 -8,955	-49%	-$73.9K	﹤0.01%	1331
2015 Q4	$178K	Buy	18,388 +10,508	+133%	+$102K	﹤0.01%	1225
2015 Q3	$69K	Hold	7,880	–	–	﹤0.01%	1375
2015 Q2	$80K	Sell	7,880 -4,776	-38%	-$55.5K	﹤0.01%	1317
2015 Q1	$170K	Buy	12,656 +1,074	+9%	+$14.1K	﹤0.01%	1204
2014 Q4	$149K	Buy	11,582 +1,672	+17%	+$19.1K	﹤0.01%	1124
2014 Q3	$108K	Buy	+9,910	New	+$113K	﹤0.01%	1167

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Capital Management Holdings's IRWD Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Ironwood Pharmaceuticals (IRWD) stake by 4.3% in Q4 2017, buying an estimated $37.4K and bringing the position to 69,573 shares worth $872K. The position accounts for 0.01% of the portfolio, ranked #926.

Cornerstone Capital Management Holdings first reported a position in IRWD in Q3 2014 and has held it in 14 quarters since. The position peaked at $1.56M in Q3 2016. 158 funds tracked by Wall St. Rank hold IRWD as of Q4 2017.

Cornerstone Capital Management Holdings held 69,573 shares of Ironwood Pharmaceuticals worth $872K as of Q4 2017.
Cornerstone Capital Management Holdings bought 2,865 Ironwood Pharmaceuticals shares in Q4 2017, an estimated $37.4K.
Ironwood Pharmaceuticals made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #926 holding.
Cornerstone Capital Management Holdings first reported a position in Ironwood Pharmaceuticals in Q3 2014 and has held it in 14 quarters since.
Cornerstone Capital Management Holdings's Ironwood Pharmaceuticals position peaked at $1.56M in Q3 2016.
158 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.